iBio, Inc. — Income Charts
14 years of history · ending 2025-06-30 · SEC EDGAR
Revenue↓-83.1% -$2M
$400K
Cost of Revenue
$216K
Gross Profit
$2M
R&D↓-16.8% -$2M
$8M
D&A↑+2.5% +$12K
$484K
Operating Income↑+40.2% +$13M
$-19M
EBITDA↑+40.9% +$13M
$-18M
Interest Expense↓-91.4% -$2M
$212K
Tax Provision
$0
Net Income↑+20.8% +$5M
$-18M
Gross Margin
115.0%
Operating Margin↓-3338.4pts
-4650.5%
Net Margin↓-3615.5pts
-4594.3%